David Lacey, MD
Physical Medicine & Rehabilitation · Fishersville, VANPI 1205838968
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 8 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations.
Across 9 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$37
- Pfizer$26
- Avanir Pharmaceuticals, Inc.$22
- AbbVie$17
- Pacira Pharmaceuticals Incorporated$16
- Avanos Medical$15
- plus $28 from 2 others
What the payments were for
- Food & beverage$160100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 1 | $37 |
| Pfizer | 2 | $26 |
| Avanir Pharmaceuticals, Inc. | 1 | $22 |
| AbbVie | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| Avanos Medical | 1 | $15 |
| Stryker | 1 | $14 |
| Relievant Medsystems, Inc. | 1 | $14 |
How this compares
$160 in reported general payments places this provider in the 55th percentile of 231 physical medicine & rehabilitation providers in Virginia.
See all physical medicine & rehabilitation providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Baclofen | 232 | $4,433 |
| Pregabalin | 32 | $1,285 |
| Gabapentin | 82 | $990 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 14 | $438 |
| Meloxicam | 184 | $391 |
| Celecoxib | 29 | $328 |
| Diclofenac Sodium | 15 | $301 |
| Methocarbamol | 19 | $299 |
| Tramadol Hcl | 52 | $297 |
| Prednisone | 54 | $282 |
| Tizanidine Hcl | 26 | $273 |
| Alendronate Sodium | 36 | $273 |
| Amitriptyline Hcl | 20 | $248 |
| Lorazepam | 27 | $19 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Fishersville
- Kovosh DastanWinchester$23K
- Stephanie ClopAldie$16K
- Daniel HellerWarrenton$12K
- Amanda MoranNorfolk$9K
- Abraham CherrickAlexandria$9K
- Mir AliRichmond$8K
- Derek BuckBluefield$7K
- Danielle CherrickMc Lean$6K
- Christopher TrowerVirginia Beach$6K
- Harnek BajajRichmond$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.